{"id":"https://openalex.org/W2017770453","doi":"https://doi.org/10.1097/bor.0000000000000000","title":"B cells","display_name":"B cells","publication_year":2013,"publication_date":"2013-11-13","ids":{"openalex":"https://openalex.org/W2017770453","doi":"https://doi.org/10.1097/bor.0000000000000000","mag":"2017770453","pmid":"https://pubmed.ncbi.nlm.nih.gov/24126901"},"language":"en","primary_location":{"id":"doi:10.1097/bor.0000000000000000","doi":"https://doi.org/10.1097/bor.0000000000000000","is_oa":false,"landing_page_url":"https://doi.org/10.1097/bor.0000000000000000","pdf_url":null,"source":{"id":"https://openalex.org/S31702427","display_name":"Current Opinion in Rheumatology","issn_l":"1040-8711","issn":["1040-8711","1080-8175","1531-6963"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Rheumatology","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086942556","display_name":"Thomas D\u00f6rner","orcid":"https://orcid.org/0000-0002-6478-7725","observed_orcids":["https://orcid.org/0000-0002-6478-7725"]},"institutions":[{"id":"https://openalex.org/I4210095248","display_name":"German Rheumatism Research Centre","ror":"https://ror.org/00shv0x82","country_code":"DE","type":"facility","lineage":["https://openalex.org/I315704651","https://openalex.org/I4210095248"]},{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Thomas D\u00f6rner","raw_affiliation_strings":["aDepartment of Rheumatology and Clinical Immunology, CC12 Department of Medicine, Deutsches Rheuma-Forschungszentrum Berlin, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany bNIAMS, NIH, Bethesda, Maryland, USA","e-mail: [email\u00a0protected]","fax: +49 30 4505 25 941","to Thomas D\u00f6rner, MD, Department of Medicine/Rheumatology and Clinical Immunology Berlin, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Charit\u00e9platz 1, 10117 Berlin, Germany. Tel: +49 30 4505 25 241"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aDepartment of Rheumatology and Clinical Immunology, CC12 Department of Medicine, Deutsches Rheuma-Forschungszentrum Berlin, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany bNIAMS, NIH, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I4210095248","https://openalex.org/I7877124"]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +49 30 4505 25 941","institution_ids":[]},{"raw_affiliation_string":"to Thomas D\u00f6rner, MD, Department of Medicine/Rheumatology and Clinical Immunology Berlin, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Charit\u00e9platz 1, 10117 Berlin, Germany. Tel: +49 30 4505 25 241","institution_ids":["https://openalex.org/I7877124"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043874873","display_name":"Peter E. Lipsky","orcid":"https://orcid.org/0000-0002-9287-1676","observed_orcids":["https://orcid.org/0000-0002-9287-1676"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210087962","display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","ror":"https://ror.org/006zn3t30","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210087962"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter E. Lipsky","raw_affiliation_strings":["NIAMS, NIH, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NIAMS, NIH, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210087962"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5086942556"],"corresponding_institution_ids":["https://openalex.org/I4210095248","https://openalex.org/I7877124"],"apc_list":null,"apc_paid":null,"fwci":0.8501,"has_fulltext":false,"cited_by_count":47,"citation_normalized_percentile":{"value":0.5952381,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"26","issue":"2","first_page":"228","last_page":"236"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9199000000953674,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9199000000953674,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.03750000149011612,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.027699999511241913,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/b-cells","display_name":"B cells","score":0.8500000238418579},{"id":"https://openalex.org/keywords/b-cell-depletion-therapy","display_name":"B-cell depletion therapy","score":0.7860000133514404},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9750000238418579},{"id":"https://openalex.org/keywords/belimumab","display_name":"belimumab","score":1.0},{"id":"https://openalex.org/keywords/mycophenolate","display_name":"mycophenolate","score":0.9700000286102295},{"id":"https://openalex.org/keywords/azathioprine","display_name":"azathioprine","score":1.0},{"id":"https://openalex.org/keywords/cd19","display_name":"CD19","score":0.8709999918937683},{"id":"https://openalex.org/keywords/cd20","display_name":"CD20","score":0.996999979019165},{"id":"https://openalex.org/keywords/cd22","display_name":"CD22","score":0.9480000138282776},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.8550000190734863},{"id":"https://openalex.org/keywords/il-21","display_name":"IL-21","score":0.9789999723434448},{"id":"https://openalex.org/keywords/baff","display_name":"BAFF","score":0.9940000176429749},{"id":"https://openalex.org/keywords/april","display_name":"APRIL","score":0.9990000128746033},{"id":"https://openalex.org/keywords/plasma-cells","display_name":"plasma cells","score":0.746999979019165},{"id":"https://openalex.org/keywords/memory-b-cells","display_name":"memory B cells","score":0.9589999914169312},{"id":"https://openalex.org/keywords/immune-activation","display_name":"immune activation","score":0.5099999904632568},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5329999923706055}],"concepts":[{"id":"https://openalex.org/C2781205201","wikidata":"https://www.wikidata.org/wiki/Q1996249","display_name":"Belimumab","level":5,"score":0.7908686995506287},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7281166911125183},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.6611682176589966},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.6561168432235718},{"id":"https://openalex.org/C170286685","wikidata":"https://www.wikidata.org/wiki/Q409346","display_name":"B-cell activating factor","level":4,"score":0.6351744532585144},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.6077552437782288},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6059238314628601},{"id":"https://openalex.org/C2776396001","wikidata":"https://www.wikidata.org/wiki/Q250694","display_name":"Plasma cell","level":3,"score":0.4847981035709381},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.46888989210128784},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.45055344700813293},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.41978591680526733},{"id":"https://openalex.org/C2776760755","wikidata":"https://www.wikidata.org/wiki/Q18939","display_name":"Azathioprine","level":3,"score":0.41804808378219604},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.36339622735977173},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.24677613377571106},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13924074172973633},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001327","descriptor_name":"Autoimmune Diseases","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D001327","descriptor_name":"Autoimmune Diseases","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007165","descriptor_name":"Immunosuppression Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D008212","descriptor_name":"Lymphocyte Depletion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012216","descriptor_name":"Rheumatic Diseases","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D012216","descriptor_name":"Rheumatic Diseases","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018858","descriptor_name":"Germinal Center","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/bor.0000000000000000","doi":"https://doi.org/10.1097/bor.0000000000000000","is_oa":false,"landing_page_url":"https://doi.org/10.1097/bor.0000000000000000","pdf_url":null,"source":{"id":"https://openalex.org/S31702427","display_name":"Current Opinion in Rheumatology","issn_l":"1040-8711","issn":["1040-8711","1080-8175","1531-6963"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Rheumatology","raw_type":"journal-article"},{"id":"pmid:24126901","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24126901","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in rheumatology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.8500000238418579,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320308970","display_name":"Teva Pharmaceutical Industries","ror":"https://ror.org/01wfv3m53"},{"id":"https://openalex.org/F4320332162","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12"},{"id":"https://openalex.org/F4320332200","display_name":"EMD Serono","ror":"https://ror.org/027zrs220"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":61,"referenced_works":["https://openalex.org/W1480160648","https://openalex.org/W1600749829","https://openalex.org/W1652931526","https://openalex.org/W1675831178","https://openalex.org/W1777560376","https://openalex.org/W1956939804","https://openalex.org/W1966457092","https://openalex.org/W1970480652","https://openalex.org/W1973318855","https://openalex.org/W1975758701","https://openalex.org/W1978259263","https://openalex.org/W1991644988","https://openalex.org/W1996710470","https://openalex.org/W2005937602","https://openalex.org/W2009686145","https://openalex.org/W2012692895","https://openalex.org/W2019873845","https://openalex.org/W2020303255","https://openalex.org/W2021273693","https://openalex.org/W2022596631","https://openalex.org/W2024266233","https://openalex.org/W2027342494","https://openalex.org/W2033603247","https://openalex.org/W2035609346","https://openalex.org/W2043347145","https://openalex.org/W2043454321","https://openalex.org/W2053620243","https://openalex.org/W2058520225","https://openalex.org/W2061053690","https://openalex.org/W2062189802","https://openalex.org/W2068383989","https://openalex.org/W2073243255","https://openalex.org/W2074051660","https://openalex.org/W2077439153","https://openalex.org/W2077770245","https://openalex.org/W2078800870","https://openalex.org/W2084056567","https://openalex.org/W2085465802","https://openalex.org/W2088004237","https://openalex.org/W2093761064","https://openalex.org/W2095955512","https://openalex.org/W2095996929","https://openalex.org/W2096880157","https://openalex.org/W2102566053","https://openalex.org/W2105893193","https://openalex.org/W2114690058","https://openalex.org/W2123082276","https://openalex.org/W2129840266","https://openalex.org/W2132838609","https://openalex.org/W2133964489","https://openalex.org/W2139012475","https://openalex.org/W2140433336","https://openalex.org/W2143000096","https://openalex.org/W2145073108","https://openalex.org/W2145345130","https://openalex.org/W2160258620","https://openalex.org/W2161537704","https://openalex.org/W2166580479","https://openalex.org/W2317430088","https://openalex.org/W4230977854","https://openalex.org/W4246504300"],"related_works":["https://openalex.org/W2074421911","https://openalex.org/W1966019751","https://openalex.org/W4408178052","https://openalex.org/W2030299551","https://openalex.org/W3090209892","https://openalex.org/W1988596351","https://openalex.org/W75207514","https://openalex.org/W3165733945","https://openalex.org/W1616773517","https://openalex.org/W2058424528"],"abstract_inverted_index":{"PURPOSE":[0],"OF":[1],"REVIEW:":[2],"The":[3,131],"availability":[4],"of":[5,20,86,95,100,111,137,162,170,180],"drugs":[6,45,89,113],"directly":[7],"and":[8,58,63,73,93,98,106,121,140,160,166,177],"indirectly":[9],"targeting":[10,51],"the":[11,18,84,96,135,158,175],"B":[12,21,69,165],"cells":[13,168],"has":[14],"refocussed":[15],"attention":[16],"on":[17,68,90,117],"role":[19],"lymphocytes":[22],"in":[23,48,134,174],"rheumatic":[24],"autoimmune/inflammatory":[25],"diseases":[26,35],"(RAIDs),":[27],"but":[28],"their":[29,115],"distinct":[30],"therapeutic":[31],"potential":[32],"for":[33],"certain":[34],"remains":[36],"to":[37,144,192],"be":[38,193],"further":[39,81,194],"assessed.":[40],"RECENT":[41],"FINDINGS:":[42],"Although":[43],"additional":[44],"are":[46,169],"currently":[47,87],"clinical":[49],"development":[50],"surface":[52],"molecules":[53],"(CD19,":[54],"CD20,":[55],"CD22,":[56],"etc.)":[57],"cytokines":[59],"(IL-6,":[60],"IL-21,":[61],"BAFF":[62],"APRIL)":[64],"with":[65,157,184],"key":[66,109,146],"effects":[67,85],"cell/plasma":[70],"cell":[71],"survival":[72,161],"differentiation,":[74],"respectively,":[75],"recent":[76],"studies":[77],"have":[78],"also":[79],"provided":[80],"insights":[82],"into":[83],"available":[88],"protective":[91],"immunity":[92],"mechanisms":[94],"initiation":[97],"progression":[99],"RAIDs":[101],"(i.e.":[102],"rituximab,":[103],"belimumab,":[104],"mycophenolate":[105],"azathioprine).":[107],"A":[108],"aspect":[110],"B-cell-directed":[112],"is":[114],"impact":[116],"continuous":[118],"immune":[119],"activation":[120],"chronic":[122],"maintenance":[123],"which":[124],"may":[125],"differ":[126],"between":[127],"individual":[128],"RAIDs.":[129],"SUMMARY:":[130],"translational":[132],"advances":[133],"area":[136],"B-cell-depleting":[138],"therapies":[139,186],"more":[141],"sophisticated":[142],"approaches":[143],"modulate":[145],"B-cell":[147,152,181],"functions,":[148],"such":[149],"as":[150],"blocking":[151],"receptor":[153],"downstream":[154],"effects,":[155],"interfering":[156],"differentiation":[159],"antigen-experienced":[163],"memory":[164],"plasma":[167],"central":[171],"interest.":[172],"Differences":[173],"efficacy":[176],"safety":[178],"profiles":[179],"depletion":[182],"compared":[183],"B-cell-modulating":[185],"(including":[187],"antigen-specific":[188],"tolerance":[189],"induction)":[190],"need":[191],"delineated.":[195]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}